Taysha Gene Therapies Inc (TSHA)

Cost of Revenue

$880.00K

TTM · Period ending: · USD

TSHA logo

TSHA Cost of Revenue

Latest reported$880.00K
TSHA TTM Cost of Revenue ($0.00 → $880.00K)
High-resolution chart · PNG

TSHA cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Taysha Gene Therapies Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
880,000
880,000
585,000
286,000
0
0
0
0
331,000
1,034,000
1,665,000
3,344,000
3,013,000
2,310,000
1,679,000
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.